| Demographic and clinical characteristics |
MS patients |
| N = 120 |
| Gender ratio (M:F) |
1:1.72 (44:76) |
| Age at onset, years, mean ± SD (range) |
30.86 ± 7.92 (16 - 55) |
| Disease course: |
| Relapsing-remitting |
60 (50.0%) |
| Secondary-progressive |
48 (40.0%) |
| Primary-progressive |
12 (10.0%) |
| Duration of the symptoms, years, mean, ± SD |
11.93 ± 8.0 |
| Duration of the disease (time of diagnosis), years, mean± SD |
6.84 ± 3.54 |
| Relapse rate per year, mean ± SD |
1.36 ± 0.88 |
| EDSSA score, mean ± SD |
4.26 ± 2.01 |
| EDSSB score, mean ± SD |
3.8 ± 1.0 |
| Patients with positive OCBs (n, %) |
88 (73.3%) |
| Demographic and clinical characteristics |
MS patients |
| N = 120 |
| Gender ratio (M:F) |
1:1.72 (44:76) |
| Age at onset, years, mean ± SD (range) |
30.86 ± 7.92 (16 - 55) |
| Disease course: |
| Relapsing-remitting |
60 (50.0%) |
| Secondary-progressive |
48 (40.0%) |
| Primary-progressive |
12 (10.0%) |
| Duration of the symptoms, years, mean, ± SD |
11.93 ± 8.0 |
| Duration of the disease (time of diagnosis), years, mean± SD |
6.84 ± 3.54 |
| Relapse rate per year, mean ± SD |
1.36 ± 0.88 |
| EDSSA score, mean ± SD |
4.26 ± 2.01 |
| EDSSB score, mean ± SD |
3.8 ± 1.0 |
| Patients with positive OCBs (n, %) |
88 (73.3%) |
| SD - standard deviation, EDSS - Expanded Disability Status Scale, EDSSA - EDSS score during last visit, EDSSB - EDSS score at time of diagnosis, OCBs- oligoclonal bands. |
|
